Fact CheckerSign in

NCT07713849Recruiting

Transition Care for FEP

Adapting and Improving Transition Care for First Episode Psychosis

Source: ClinicalTrials.gov · Last updated 20 Jul 2026

Brief summary (registry, in English)

This study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care. Many patients lose contact with services after they leave the hospital, which can lead to worse outcomes. The investigators have developed a Transition Care Team (TCT) that works with patients while they are in the hospital and continues to support them after discharge. The team provides therapy, case management, and coordination with community programs that offer ongoing care. The main goal of the study is to find out if this new program increases the number of patients who successfully begin outpatient treatment after hospitalization, compared to usual care. The investigators will also look at whether the program improves symptoms, functioning, and overall well-being.

Status (registry)
Recruiting
Study type
Observational
Enrollment
75 (estimated)
First submitted
2 Jul 2026
Start date
6 May 2026
Primary completion date
6 May 2028
Lead sponsor
University of Chicago
NCT number
NCT07713849

What you commit to

  • Study type: Observational
  • Planned participants: 75
  • From 6 May 2026 to the primary completion date, 6 May 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with substance-induced psychosis or psychosis due to a medical condition will not be included in the study. We will use the Structured Clinical Interview for DSM-5 as well as medical records, and if the subject gives permission, caregiver information in this process

Other

  • Individuals who do not meet criteria for a first episode of psychosis

Who the study is looking for

  • Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, major depressive disorder with psychotic features, schizophreniform disorder, or psychosis NOS
  • The diagnosis of one of the psychotic disorders has a duration of less than two years.
  • Able to read, speak, and understand English, which will be assessed through observation.
  • Able and willing to provide written informed consent or assent, in cases where caregivers are considered legal guardians. Dr. Shima, co-I of the study, is a forensic psychiatrist, and particularly adept at judging such ability. Drs. Erickson and Keedy have conducted studies in individuals with psychotic disorders, including FEP and in the context of clinical trials, for years, and are similarly competent to judge whether individuals can provide informed consent. Finally, we will also use an Evaluation to Sign Consent form that documents subjects' verbalized understanding of key aspects of the study.
  • have an estimated IQ of \> 65, assessed by the Wechsler Test of Adult Reading
  • Eligible caregivers/proxy informants must be identified by the participant or clinical team as being involved in the participant's discharge planning or follow-up care, be able to provide informed verbal consent, and be able to speak and read English sufficiently to complete study questionnaires. Caregivers may include family members, close supports, or legally authorized representatives.

Age in the registry: 18 years to 40 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Chicago Medical Center, Biological Science Division
Coordinator of this site? Confirm its status
ChicagoUnited StatesActive, not recruiting
University of Chicago Ingalls Memorial Hospital
Coordinator of this site? Confirm its status
HarveyUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.